{
    "journal": {
        "id": "eLife", 
        "title": "eLife", 
        "issn": "2050-084X"
    }, 
    "snippet": {
        "-meta": {
            "location": "https://raw.githubusercontent.com/elifesciences/elife-article-xml/01cf41ef9c1c805dcc0b78b3fb09dd4da4e52c38/articles/elife-03751-v1.xml"
        }, 
        "status": "poa", 
        "id": "03751", 
        "version": 1, 
        "type": "research-article", 
        "doi": "10.7554/eLife.03751", 
        "authorLine": "Igor Vivanco et al", 
        "title": "A kinase-independent function of AKT promotes cancer cell survival", 
        "published": "2014-12-31T00:00:00Z", 
        "versionDate": "2014-12-31T00:00:00Z", 
        "volume": 3, 
        "elocationId": "e03751", 
        "pdf": "https://publishing-cdn.elifesciences.org/03751/elife-03751-v1.pdf", 
        "subjects": [
            {
                "id": "cell-biology", 
                "name": "Cell Biology"
            }, 
            {
                "id": "human-biology-medicine", 
                "name": "Human Biology and Medicine"
            }
        ], 
        "researchOrganisms": [
            "Human", 
            "Mouse"
        ], 
        "abstract": {
            "content": [
                {
                    "type": "paragraph", 
                    "text": "The serine-threonine kinase AKT regulates proliferation and survival by phosphorylating a network of protein substrates. Here we describe a kinase-independent function of AKT. In cancer cells harboring gain-of-function alterations in MET, HER2, or Phosphatidyl-Inositol-3-Kinase (PI3-K), catalytically-inactive AKT (K179M) protected from druginduced cell death in a PH-domain dependent manner. An AKT kinase domain mutant found in human melanoma (G161V) lacked enzymatic activity in-vitro and in AKT1/AKT2 double knockout cells, but promoted growth-factor independent survival of primary human melanocytes. ATP-competitive AKT inhibitors failed to block the kinase-independent function of AKT, a liability that limits their effectiveness compared to allosteric AKT inhibitors. Our results broaden the current view of AKT function and have important implications for the development of AKT inhibitors for cancer."
                }
            ]
        }
    }, 
    "article": {
        "-meta": {
            "location": "https://raw.githubusercontent.com/elifesciences/elife-article-xml/01cf41ef9c1c805dcc0b78b3fb09dd4da4e52c38/articles/elife-03751-v1.xml", 
            "patched": true
        }, 
        "status": "poa", 
        "id": "03751", 
        "version": 1, 
        "type": "research-article", 
        "doi": "10.7554/eLife.03751", 
        "authorLine": "Igor Vivanco et al", 
        "title": "A kinase-independent function of AKT promotes cancer cell survival", 
        "published": "2014-12-31T00:00:00Z", 
        "versionDate": "2014-12-31T00:00:00Z", 
        "volume": 3, 
        "elocationId": "e03751", 
        "pdf": "https://publishing-cdn.elifesciences.org/03751/elife-03751-v1.pdf", 
        "subjects": [
            {
                "id": "cell-biology", 
                "name": "Cell Biology"
            }, 
            {
                "id": "human-biology-medicine", 
                "name": "Human Biology and Medicine"
            }
        ], 
        "researchOrganisms": [
            "Human", 
            "Mouse"
        ], 
        "abstract": {
            "content": [
                {
                    "type": "paragraph", 
                    "text": "The serine-threonine kinase AKT regulates proliferation and survival by phosphorylating a network of protein substrates. Here we describe a kinase-independent function of AKT. In cancer cells harboring gain-of-function alterations in MET, HER2, or Phosphatidyl-Inositol-3-Kinase (PI3-K), catalytically-inactive AKT (K179M) protected from druginduced cell death in a PH-domain dependent manner. An AKT kinase domain mutant found in human melanoma (G161V) lacked enzymatic activity in-vitro and in AKT1/AKT2 double knockout cells, but promoted growth-factor independent survival of primary human melanocytes. ATP-competitive AKT inhibitors failed to block the kinase-independent function of AKT, a liability that limits their effectiveness compared to allosteric AKT inhibitors. Our results broaden the current view of AKT function and have important implications for the development of AKT inhibitors for cancer."
                }
            ]
        }, 
        "copyright": {
            "license": "CC-BY-4.0", 
            "holder": "Vivanco et al", 
            "statement": "This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited."
        }, 
        "authors": [
            {
                "type": "person", 
                "name": {
                    "preferred": "Igor Vivanco", 
                    "index": "Vivanco, Igor"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Human Oncology and Pathogenesis Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Zhi C Chen", 
                    "index": "Chen, Zhi C"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Human Oncology and Pathogenesis Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Barbara Tanos", 
                    "index": "Tanos, Barbara"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Cell Biology Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Barbara Oldrini", 
                    "index": "Oldrini, Barbara"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Seve Ballesteros Foundation Brain Tumor Group", 
                            "Spanish National Cancer Research Centre"
                        ], 
                        "address": {
                            "formatted": [
                                "Madrid", 
                                "Spain"
                            ], 
                            "components": {
                                "locality": [
                                    "Madrid"
                                ], 
                                "country": "Spain"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Wan-Ying Hsieh", 
                    "index": "Hsieh, Wan-Ying"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Department of Pharmacology", 
                            "Weill-Cornell Graduate School of Biomedical Sciences"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Nicolas Yannuzzi", 
                    "index": "Yannuzzi, Nicolas"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Human Oncology and Pathogenesis Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Carl Campos", 
                    "index": "Campos, Carl"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Human Oncology and Pathogenesis Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }, 
            {
                "type": "person", 
                "name": {
                    "preferred": "Ingo K Mellinghoff", 
                    "index": "Mellinghoff, Ingo K"
                }, 
                "affiliations": [
                    {
                        "name": [
                            "Human Oncology and Pathogenesis Program", 
                            "Memorial Sloan-Kettering Cancer Center"
                        ], 
                        "address": {
                            "formatted": [
                                "New York", 
                                "United States"
                            ], 
                            "components": {
                                "locality": [
                                    "New York"
                                ], 
                                "country": "United States"
                            }
                        }
                    }
                ], 
                "emailAddresses": [
                    "mellingi@mskcc.org"
                ], 
                "competingInterests": "The authors declare that no competing interests exist."
            }
        ], 
        "additionalFiles": [
            {
                "mediaType": "application/zip", 
                "uri": "https://publishing-cdn.elifesciences.org/03751/elife-03751-supp-v1.zip", 
                "filename": "elife-03751-supp-v1.zip", 
                "id": "SD1-data", 
                "title": "Supplementary file 1."
            }
        ], 
        "stage": "published", 
        "statusDate": "2099-01-01T00:00:00Z"
    }
}